Reconstitution of the alternative pathway of the complement system enables rapid delineation of the mechanism of action of novel inhibitors
Open Access
- 12 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (7) , 107467
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Complement in the pathogenesis of Alzheimer’s diseaseSeminars in Immunopathology, 2017
- The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatmentMolecular Immunology, 2017
- Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndromeTranslational Research, 2015
- Evaluation of Complement Function by ELISA2013
- New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic propertiesImmunobiology, 2013
- A Tick Mannose-Binding Lectin Inhibitor Interferes with the Vertebrate Complement Cascade to Enhance Transmission of the Lyme Disease AgentCell Host & Microbe, 2011
- Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potencyMolecular Immunology, 2011
- Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3bJournal of Molecular Biology, 2010
- Complement control protein factor H: The good, the bad, and the inadequateMolecular Immunology, 2010
- Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factorJournal of Pharmacological and Toxicological Methods, 2005